Jiangsu SinoExci BioPharma Co., Ltd.
— Pharmaceutical-grade R&D capability · Made in China
SinoExci delivers high-end, specialty excipients for pharmaceutical formulations — cutting China's import dependency.
R&D of high-end, next-gen excipients
Application research linking excipients to formulations
End-to-end CDE registration support
Localized production for secure, stable supply
From conventional solvents to fluorinated specialty materials — a functional excipient matrix covering every formulation scenario.
Pyrrolidones, glycols, esters and fluorinated systems to tackle any dissolution challenge.
View Series → 02Refined vegetable oils and glycerides for lipid-based drug delivery systems.
View Series → 03Esters, keto acids and more — engineered for transdermal and topical permeation enhancement.
View Series → 04High-HLB non-ionic emulsifying and solubilizing agents as import alternatives.
View Series → 05Alkyl glucosides and ester-based emulsifiers for stable emulsion systems.
View Series → 06Long-chain sucrose ester molecules powering long-acting injectable release platforms.
View Series → 07Volatile cyclic siloxanes delivering a light, silky feel for topical applications.
View Series → +Multiple pipelines are advancing through registration. Contact us to explore cooperation.
View All →Representative products with active CDE registration numbers — ready for commercial supply with full registration support.
Solvent for Injection · Preservative
Solvent for Injection · Preservative
Solvent for Injection · Preservative
Solvent for Injection · Preservative
Solvent for Injection · Preservative
Solvent for Injection · Preservative
Solvent for Injection · Preservative
Solvent for Injection · Preservative
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
Read More →
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
Read More →
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
Read More →
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
Read More →
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
Read More →
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
Read More →Request samples, technical documentation or registration support — our applied science team is ready to help you develop better medicines.
